참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Rofecoxib | HCID 5090 | — |
| 반응물 | Diisobutylaluminum hydride | HCID 14487 | — |
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | (2Z)-2-[4-(methylsulfonyl)phenyl]-3-phenylbut-2-ene-1,4-diol | HCID 57434773 | 98.7% |
반응 단계
To a solution of 110 g of 4-(4-methanesulfonyl-phenyl)-3-phenyl-5H-furan-2-one in 1.5 L of dichloromethane stirred at −78° C., 150 mL of DIBAL was added dropwise. The resulting mixture was warmed to room temperature and stirred overnight. The reaction mixture was then cooled to −78° C., and 1.2 L of 1 M aqueous NaOH was added dropwise. After the addition, the resulting mixture was warmed to room temperature and the organic phase was separated. The aqueous phase was extracted with dichloromethane. The organic phases were combined and dried over Na2SO4. 110 g of the titled compound was obtained after evaporation. 1H NMR (acetone-d6, 500 M Hz): δ 7.69 (d, 2 H), 7.36 (d, 2 H), 7.16–7.05 (m, 5 H), 4,66 (d, 2 H), 4.63 (d, 2 H), 4.19 (t, 1 H, OH), 4.17 (t, 1 H. OH), 3.04 (s, 3 H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07199154B2 |
|---|
| 출처 데이터셋 | uspto-grants-2007_04 |
|---|
| ORD ID | ord-a0d1798d1a4a4937b9d1bbf49333574c |
|---|
| 출처 메모 | uspto-grants-2007_04 |
|---|